Princeton-based WIRB-Copernicus Group‘s clinical services division, a provider of solutions for clinical research, announced Tuesday it has acquired ACI Clinical, a provider of endpoint adjudication and data monitoring safety committees.
“We are delighted to welcome ACI Clinical to the WCG family of companies,” said Donald A. Deieso, chairman and CEO of WCG. “With its industry leading clinical trial committees and clinical trial advisory services, ACI Clinical provides clients with expert reviews that deliver reliable and trusted information to support critical decisions around clinical development programs. ACI Clinical manages a global network of more than 500 medical, statistical and safety experts that can serve as committee members and advisors to our clients.”
“ACI is thrilled to join WCG,” said Jonathan Seltzer, CEO and president of ACI Clinical. “Our Endpoint Adjudication and Safety Monitoring Committees are a valuable addition to WCG’s existing portfolio of product safety solutions. Together with WCG, we will work with clinical trial sponsors, academic experts and regulatory agencies to enhance trial integrity, reduce variation in important clinical trial events and ultimately mitigate risk and enhance patient safety in clinical trials.”
Under terms of the deal, ACI Clinical will continue to operate as an independent organization within WCG’s clinical service division.
Financial terms were not disclosed.